Lactational exposure to atypical antipsychotic drugs disrupts the pituitary-testicular axis in mice neonates during post-natal development

Journal of Psychopharmacology

Volumn 24, Issue 7, 2010, Pages 1097-1104

  Mishra, Akash C ^a   Mohanty, Banalata ^a  

^a UNIVERSITY OF ALLAHABAD   (India)

Author keywords

Lactational exposure; Mice neonates; Olanzapine; Pituitary testicular axis; Risperidone

Indexed keywords

LUTEINIZING HORMONE; OLANEX; OLANZAPINE; PROLACTIN; RESPIDON; RISPERIDONE; TESTOSTERONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; FETUS; GERM CELL; GONADOTROPIN SECRETING CELL; HISTOPATHOLOGY; HYPOGONADISM; HYPOPHYSIS TESTIS SYSTEM; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; LACTATION; MALE; MORPHOMETRICS; MOUSE; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROLACTIN SECRETING CELL; REPRODUCTIVE TOXICITY; SEMINIFEROUS TUBULE; TESTIS WEIGHT; TESTOSTERONE BLOOD LEVEL;

ANIMALS; ANIMALS, NEWBORN; ANTIPSYCHOTIC AGENTS; FEMALE; IMMUNOHISTOCHEMISTRY; LACTATION; LUTEINIZING HORMONE; MALE; MICE; MILK; ORGAN SIZE; PITUITARY GLAND; PITUITARY HORMONES; PROLACTIN; TESTIS; TESTOSTERONE;

EID: 77953761619     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881109348162     Document Type: Article

References (51)

1. Ader M., Kim SP, Catalano KJ, et al. (2005) Metabolic dysregulation with atypical antipsychotics occurs in the absence of underlying disease. A placebo-controlled study of olanzapine and risperidone in dogs. Diabetes 54: 862-871.
2. Agrawal P., Bhatia MS, Malik SC (1997) Post-partum psychosis: A clinical study. Int J Social Psychiatry 43: 217-222.
3. Baptista T., Araujo de Baptista E., Ying Kin NM, et al. (2002) Comparative effects of the antipsychotics sulpiride or risperidone in rats. I: Bodyweight, food intake, body composition, hormones and glucose tolerance. Brain Res 957: 144-151.
4. Bartke A., Amador A., Chandrashekar V., Klemcke HG (1987 a) Seasonal differences in testicular receptors and steroidogenesis. J Steroid Biochem 27: 581-587.
5. Bartke A., Morgan WW, Clayton RN, et al. (1987 b) Neuroendocrine studies in hyperprolactinaemic male mice. J Endocrinol 112: 215-220.
6. Bobes J., Garc Apmp, Rajas J., et al. (2003) Frequency of sexual dysfunction and other reproductive side effects in patients with schizophrenia treated with olanzapine, quetiapine, or haloperidol: The results of the EIRE study. J Sex Marital Ther 29: 125-147.
7. Byerlya MJ, Nakoneznyb PA, Bettchera BM, Carmodyb T., Fishera R., Ruschc AJ (2006) Sexual dysfunction associated with second-generation antipsychotics in outpatients with schizophrenia or schizoaffective disorder: An empirical evaluation of olanzapine, risperidone, and quetiapine. Schizophrenia Res 86: 244-250.
8. Casey DE, Zorn SH (2001) The pharmacology of weight gain with antipsychotics. J Clin Psychiatry 62: 4-10.
9. Coccurello R., Caprioli A., Conti R., et al. (2008) Olanzapine but not the novel atypical antipsychotic ST2472 chronic administration induces weight gain, hyperphagia and metabolic dysregulation in mice. JPET 326: 905-911.
10. Compton MT, Miller AH (2002) Antipsychotic-induced hyperprolactinemia and sexual dysfunction. Psychopharmacology Bull 36: 143-164.
11. Cutler AJ (2003) Sexual dysfunction and antipsychotic treatment. Psychoneuroendocrinology 28: 69-82.
12. Fell MJ, Marshall KM, Neill JC (2004 a) Effects of the classical antipsychotic haloperidol and atypical antipsychotic risperidone on weight gain, the oestrous cycle and uterine weight in female rats. Eur Neuropsychopharmacol 14: 385-392.
13. Fell MJ, Neill JC, Rao C., Marshall KM (2005) Effects of sub-chronic antipsychotic drug treatment on body weight and reproductive function in juvenile female rats. Psychopharmacology 182: 499-507.
14. Fell MJ, Williams J., Marshall KM, Neill JC (2004 b) Effects of the atypical antipsychotic olanzapine on reproductive function and weight gain in female rats. J Psychopharmacol 18: 149-155.
15. Gardiner SJ, Kristensen JH, Hackett LP, Ilett KF, Rampono J. (2003) Transfer of olanzapine into breast milk calculation of infant drug dose and effect on breast fed infants. Am J Psychiatry 160: 1428-1431.
16. Gerald A., Maquine MD (2002) Prolactin elevation with antipsychotic medications: mechanism of action and clinical consequences. J Clin Psychiatry 63: 56-62.
17. Goldstein DJ, Gorbin IA, Fung MC (2000) Olanzapine exposed pregnancies and lactation: early experience. J Clin Psychopharmacol 20: 399-403.
18. Grattan DR, Jasoni CL, Liu X., Anderson GM, Herbison AE (2007) Prolactin regulation of gonadotropin-releasing hormone neurons to suppress luteinizing hormone secretion in mice. Endocrinology 148: 4344-4351.
19. Haddad P. (2005) Weight change with atypical antipsychotics in the treatment of schizophrenia. J Psychopharmacol 19: 16-27.
20. Haefliger T., Bonsack C. (2006) Atypical antipsychotics and sexual dysfunction: five case reports associated with risperidone. Encephale 32: 97-105.
21. Harvey PW, Everett DJ, Springall CJ (2008) Adverse effects of prolactin in rodents and humans: breast and prostate cancer. J Psychopharmacol 22: 20-27.
22. Hellewell JSE, Gerlach JES (2000) Opportunities and challenges presented by the new generation antipsychotics. Int J Psychiatry Clin Practice 4: 53-61.
23. Hsu SM, Raine L., Fanger H. (1981) Use of avidine-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29: 577-580.
24. Huseby RA, Soares MJ, Talamantes F. (1985) Ectopic pituitary grafts in mice: Hormone levels, effects on fertility, and the development of adenomyosis uteri, prolactinomas, and mammary carcinomas. Endocrinology 116: 1440-1448.
25. Ilett KF, Hackett LP, Kristensen JH, Vaddadi KS, Gardiner SJ, Begg EJ (2004) Transfer of risperidone and 9-hydroxy risperidone into human milk. Ann Pharmacother 38: 273-276.
26. Jayaram MB, Hosalli P. (2005) Risperidone versus olanzapine for schizophrenia. Cochrane Database Syst Rev 18: CD005237.
27. Jin L., Qian X., Kulig E., et al. (1997) Prolactin receptor messenger ribonucleic acid in normal and neoplastic human pituitary tissues. J Clin Endocrinol Metab 82: 963-968.
28. Kaneda Y., Ohmori T. (2003) Impact of risperidone medication on quality of life and gonadal axis hormones in schizophrenia male patients with acute exacerbation. Int J Neur Psychopharmacol 6: 247-252.
29. Kapur S., Vanderspek SC, Brownlee BA, Nobrega JN (2003) Antipsychotic dosing in preclinical models is often unrepresentative of the clinical conditions: A suggested solution based on in vivo occupancy new hypothesis. J Pharmacol Exp Ther 305: 625-631.
30. Kapur S., Zipursky RB, Remington G., et al. (1998) 5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: A PET investigation. Am J Psychiatry 155: 928-931.
31. Kinon BJ, Ahl J., Liu-Seifert H., Maguire GA (2006) Improvement in hyperprolactinemia and reproductive comorbidities in patients with schizophrenia switched from conventional antipsychotics or risperidone to olanzapine. Psychoneuroendocrinology 31: 577-588.
32. Knegtering H., Vandermoolen AE, Castelein S., Kluiter H., Vanderbosch RJ (2003) What are the effects of antipsychotics on sexual dysfunction and endocrine functioning ? Psychoneuroendocrinology 28: 109-123.
33. Konarzewska B., Wołczýnski S., Szulc A., Galińska B., Popławska R., Waszkiewicz N (2009) Effect of risperidone and olanzapine on reproductive hormones, psychopathology and sexual functioning in male patients with schizophrenia. Psychoneuroendocrinology 34: 129-139.
34. Lewis CE, Fink G., Dow RC, Morris JF (1986) Hyperprolactinemia induced by pituitary isografts suppresses the priming effect of LH-releasing hormone in normal and hypogonadal mice. Neuroendocrinology 43: 584-589. (Pubitemid 16041232)
35. Meaney AM, OKeane V. (2002) Prolactin and schizophrenia: clinical consequences of hyperprolactinaemia. Life Sciences 71: 979-992.
36. Mishra AC, Mohanty B. (2009) Effect of lactational olanzapine exposure on body weight of mice: A comparative study on neonates of both the sexes during post-natal development. J Psychopharmacol, 0269881108100775v1.
37. Morel G., Ouhtit A., Kelly PA (1994) Prolacin receptor immunoreactivity in rat anterior pituitary. Neuroendocrinology 59: 78-84. (Pubitemid 24026917)
38. Park SK, Keenan MW, Selmanoff M. (1993) Graded hyperprolactinemia first suppresses LH pulse frequency and then pulse amplitude in castrated male rats. Neuroendocrinology 58: 448-453.
39. Perryman RL, Thorner MO (1981) The effects of hyperprolactinemia on sexual and reproductive function in men. J Androl 2: 233-242.
40. Pritchard DB, Harris B. (1996) Aspects of perinatal psychiatric illness. Br J Psychiatry 169: 555-562.
41. Romanowicz K., Misztal T., Barcikowski B. (2004) The effects of intra-cerebroventricular infusion of prolactin on lutenizing hormone, testosterone and growth hormone secretion in male sheep. J Ani Reprod Sci 81: 261-272.
42. Rourke C., Starr KR, Reavill C., Fenwick S., Deadman K., Jones DNC (2006) Effects of the atypical antipsychotic olanzapine and risperidone on plasma prolactin levels in male rats: a comparison with clinical data. Psychopharmacology 184: 107-114.
43. Schotte A., Janssen PF, Gommeren W., et al. (1996) Risperidone compared with new and reference antipsychotic drugs: In vitro and in vivo receptor binding. Psychopharmacology 124: 57-73.
44. Smith SM (2008) The impact of hyperprolactinemia on sexual function in patients with psychosis. J Psychopharmacol 22: 63-69.
45. Smith S., Wheelar MJ, Murrey R., OKeone V. (2002) The effect of antipsychotic induced hyperprolactinemia on the endocrine/ reproductive system. J Clin Psychopharmacol 22: 109-114.
46. Tortonese DJ, Brooks J., Ingleton PM, McNeilly AS (1998) Detection of prolactin receptor gene expression in sheep pituitary gland and visualization of the specific translation of the signal in gonadotrophs. Endocrinology 139: 5215-5223.
47. Vestri HS, Maianu L., Moellering DR, Garvey WT (2007) Atypical antipsychotic drugs directly impair insulin action in adipocytes: Effects on glucose transport, lipogenesis, and antilipolysis. Neuropsychopharmacology 32: 765-772.
48. Volavaka J., Czober P., Cooper TB, et al. (2004) Prolactin levels in schizophrenia and schizoeffective disorder patient treated with clozapine, olanzapine, risperidone or haloperidol. J Clin Psychiatry 65: 57-61.
49. Wetterling T. (2001) Body weight gain with atypical antipsychotics, A comparative review. Drug Safety 24: 59-73.
50. Williams VL, DeGuzman A., Dang H., et al. (2007) Common and specific effects of the two major forms of prolactin in the rat testis. Am J Physiol Endocrinol Metab 293: E1795 - E1803.
51. Wudarsky M., Nicolson R., Hamburger SD, et al. (1999) Elevated prolactin in pediatric patients on typical and atypical antipsychotics. J Child Adolesc Psychopharmacol 9: 239-245.